Your browser doesn't support javascript.
loading
Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.
Gilad, Oded; Dgany, Orly; Noy-Lotan, Sharon; Krasnov, Tanya; Yacobovich, Joanne; Rabinowicz, Ron; Goldberg, Tracie; Kuperman, Amir A; Abu-Quider, Abed; Miskin, Hagit; Kapelushnik, Noa; Mandel-Shorer, Noa; Shimony, Shai; Harlev, Dan; Ben-Ami, Tal; Adam, Etai; Levin, Carina; Aviner, Shraga; Elhasid, Ronit; Berger-Achituv, Sivan; Chaitman-Yerushalmi, Lilach; Kodman, Yona; Oniashvilli, Nino; Hameiri-Grosman, Michal; Izraeli, Shai; Tamary, Hannah; Steinberg-Shemer, Orna.
Afiliación
  • Gilad O; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
  • Dgany O; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.
  • Noy-Lotan S; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.
  • Krasnov T; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.
  • Yacobovich J; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
  • Rabinowicz R; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
  • Goldberg T; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
  • Kuperman AA; Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed.
  • Abu-Quider A; Pediatric Hematology, Soroka University Medical Center, Ben-Gurion University, Beer Sheva.
  • Miskin H; Pediatric Hematology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem.
  • Kapelushnik N; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Goldschleger Eye Institute, Sheba Medical Center, Hashomer.
  • Mandel-Shorer N; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Healthcare Campus; Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa.
  • Shimony S; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Rabin Medical Center, Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Petach-Tikva, Israel; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Harlev D; Pediatric Hematology-Oncology Department, Hadassah University Medical Center, Jerusalem.
  • Ben-Ami T; Pediatric Hematology Unit, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem.
  • Adam E; Pediatric Hematology-Oncology Department, Sheba Medical Center, Hashomer.
  • Levin C; Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel; Pediatric Hematology Unit and Research Laboratory, Emek Medical Center, Afula.
  • Aviner S; Department of Pediatrics, Barzilai University Medical Center, Ashkelon, affiliated to Ben Gurion University, Beer-Sheva.
  • Elhasid R; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center.
  • Berger-Achituv S; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center.
  • Chaitman-Yerushalmi L; Genoox, Health Care Technology, Aviv.
  • Kodman Y; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.
  • Oniashvilli N; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.
  • Hameiri-Grosman M; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.
  • Izraeli S; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.
  • Tamary H; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva. htamary@tauex.tau.ac.il.
  • Steinberg-Shemer O; Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.
Haematologica ; 107(9): 2081-2095, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35295078
ABSTRACT
Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Síndromes Mielodisplásicos / Leucemia / Anemia Aplásica / Neutropenia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Síndromes Mielodisplásicos / Leucemia / Anemia Aplásica / Neutropenia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article
...